(Q50630840)

16 March 2018

title

Transfusion medicine in a developing country - alloantibodies to red blood cells in multi-transfused patients in Saudi Arabia. (English)

1 reference

16 March 2018

1 reference

Abdel Galil M Abdel Gader

series ordinal

1

1 reference

16 March 2018

Abeer K Al Ghumlas

series ordinal

2

1 reference

16 March 2018

Abdel Kareem M Al-Momen

series ordinal

3

1 reference

16 March 2018

publication date

23 October 2008

1 reference

16 March 2018

Transfusion and Apheresis Science

published in

1 reference

16 March 2018

volume

39

1 reference

16 March 2018

issue

3

1 reference

16 March 2018

page(s)

199-204

1 reference

16 March 2018

Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.09.013

Red cell antibodies in patients with homozygous sickle cell disease: a comparison of patients in Jamaica and the United Kingdom

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.09.013

Red blood cell alloimmunization in sickle cell disease: the influence of racial and antigenic pattern differences between donors and recipients in Brazil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.09.013

RBC alloimmunization and autoimmunization among transfusion‐dependent Arab thalassemia patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.09.013

Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.09.013

Predicting the effect of transfusing only phenotype-matched RBCs to patients with sickle cell disease: theoretical and practical implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.09.013

The incidence of development of irregular red cell antibodies in patients with sickle cell anemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.09.013

Antigen-matched donor blood in the transfusion management of patients with sickle cell disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.09.013

Alloimmunization among patients with transfusion-dependent thalassemia in Taiwan.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.09.013

Red cell alloantibodies in patients with thalassemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.09.013

Should chronic transfusions be matched for antigens other than ABO and Rho(D)?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.09.013

Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.09.013

Erythrocyte autoantibodies in paediatric patients with sickle cell disease receiving transfusion therapy: frequency, characteristics and significance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.09.013

Coexistence of autoantibodies and alloantibodies to red blood cells due to blood transfusion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.09.013

Allosensitization in patients receiving multiple blood transfusions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.09.013

Warm reactive autoantibodies: clinical and serologic correlations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.09.013

10.1016/J.TRANSCI.2008.09.013

7 January 2021

Identifiers

DOI

1 reference

16 March 2018

PubMed ID

18951063

1 reference

16 March 2018